华北制药
(600812)
| 流通市值：102.09亿 | | | 总市值：102.09亿 |
| 流通股本：17.16亿 | | | 总股本：17.16亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,996,264,315.21 | 1,660,278,671.77 | 1,721,574,148.94 | 1,770,138,674.36 |
| 应收票据及应收账款 | 2,324,234,183.39 | 2,049,376,568.87 | 2,171,924,917.65 | 2,264,221,256.42 |
| 应收账款 | 2,324,234,183.39 | 2,049,376,568.87 | 2,171,924,917.65 | 2,264,221,256.42 |
| 应收款项融资 | 238,473,978.01 | 242,448,937.63 | 261,103,108.5 | 199,569,181.33 |
| 预付款项 | 224,232,494.26 | 213,219,933.01 | 257,383,074.89 | 245,353,484.56 |
| 其他应收款合计 | 1,496,996,714.27 | 1,436,372,128.81 | 1,643,268,158.02 | 1,499,334,081.64 |
| 其中:应收利息 | 4,433,895.06 | 3,264,682.4 | 2,224,831.22 | 1,017,592.99 |
| 应收股利 | - | 60,000,000 | - | - |
| 存货 | 2,395,392,879.99 | 2,510,534,823.14 | 2,460,136,846.55 | 2,605,606,932.98 |
| 其他流动资产 | 118,952,521.76 | 147,048,806.61 | 158,144,411.48 | 167,216,264.76 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 8,794,547,086.89 | 8,259,279,869.84 | 8,673,534,666.03 | 8,751,439,876.05 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,194,470,653.78 | 1,187,039,254.62 | 1,234,619,664.01 | 1,223,752,172.58 |
| 其他权益工具投资 | 17,700,000 | 17,700,000 | 17,465,000 | 17,465,000 |
| 固定资产 | 6,366,526,858.25 | 6,298,709,576.2 | 6,517,242,411.08 | 6,642,012,943.79 |
| 在建工程 | 428,736,632.49 | 381,136,756.29 | 349,270,261.43 | 280,501,629.25 |
| 使用权资产 | 351,491,034.14 | 581,378,283.93 | 408,466,234.58 | 427,768,349.33 |
| 无形资产 | 2,713,918,431.12 | 2,755,997,485.79 | 2,210,506,830.56 | 2,096,756,491.89 |
| 开发支出 | 1,991,398,427.62 | 1,851,668,702.51 | 2,185,474,341.39 | 2,200,303,388.17 |
| 商誉 | - | - | 3,336,585.26 | 3,336,585.26 |
| 长期待摊费用 | 62,808,414.5 | 66,114,322.63 | 54,765,419.32 | 55,917,448.96 |
| 递延所得税资产 | 72,434,064.62 | 72,434,064.62 | 52,109,827.43 | 52,109,827.43 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 13,199,484,516.52 | 13,212,178,446.59 | 13,033,256,575.06 | 12,999,923,836.66 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 21,994,031,603.41 | 21,471,458,316.43 | 21,706,791,241.09 | 21,751,363,712.71 |
| 流动负债: | | | | |
| 短期借款 | 7,522,013,153.44 | 7,094,995,438.88 | 6,756,470,000 | 5,981,085,000 |
| 应付票据及应付账款 | 2,618,566,664.15 | 2,295,077,225.16 | 2,583,058,365.41 | 2,720,802,822.13 |
| 其中：应付票据 | 762,560,000 | 451,196,780.05 | 633,245,011.58 | 622,553,682.71 |
| 应付账款 | 1,856,006,664.15 | 1,843,880,445.11 | 1,949,813,353.83 | 2,098,249,139.42 |
| 合同负债 | 205,234,149.22 | 281,751,156.27 | 258,541,625.59 | 251,719,209.73 |
| 应付职工薪酬 | 185,635,960.75 | 183,943,890.68 | 191,039,501.7 | 187,448,949.95 |
| 应交税费 | 62,563,698.91 | 40,657,143.51 | 67,485,288.16 | 65,766,367.33 |
| 其他应付款合计 | 374,380,280.51 | 395,473,727.32 | 410,586,425.49 | 457,575,144.72 |
| 其中:应付利息 | 2,612,394.61 | 675,564 | 1,949,524.43 | 19,057.5 |
| 应付股利 | 385,687.5 | 385,687.5 | 1,797,687.5 | 18,954,991.2 |
| 一年内到期的非流动负债 | 1,004,671,227.95 | 632,496,733.34 | 791,896,718.01 | 1,708,699,634.63 |
| 其他流动负债 | 52,455,944.75 | 37,134,683.26 | 18,471,397.6 | 2,074,373.51 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 12,025,521,079.68 | 10,961,529,998.42 | 11,077,549,321.96 | 11,375,171,502 |
| 非流动负债: | | | | |
| 长期借款 | 2,858,389,000 | 3,458,920,560.64 | 3,841,790,560.64 | 3,623,247,958.57 |
| 租赁负债 | 246,182,271.34 | 263,531,519.71 | 146,279,993.47 | 163,973,611.69 |
| 长期应付款 | 9,735,000 | 9,735,000 | 900,000 | 900,000 |
| 递延收益 | 73,228,799.89 | 74,024,417.65 | 34,687,829.77 | 33,457,729.97 |
| 递延所得税负债 | 29,103,732.43 | 29,103,732.43 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 3,216,638,803.66 | 3,835,315,230.43 | 4,023,658,383.88 | 3,821,579,300.23 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 15,242,159,883.34 | 14,796,845,228.85 | 15,101,207,705.84 | 15,196,750,802.23 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,715,730,370 | 1,715,730,370 | 1,715,730,370 | 1,715,730,370 |
| 资本公积 | 3,862,215,449.63 | 3,862,187,679.3 | 3,862,201,522.06 | 3,859,238,032.3 |
| 其他综合收益 | 7,975,384.51 | 7,935,661.63 | 6,183,858.59 | 7,126,398.64 |
| 专项储备 | 885,226.62 | 319,749.33 | 1,553,929.9 | 1,549,440.87 |
| 盈余公积 | 333,357,636.58 | 333,357,636.58 | 322,436,110.73 | 322,436,110.73 |
| 未分配利润 | -472,636,526.69 | -530,128,112.73 | -543,735,315.87 | -574,214,561.19 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,447,527,540.65 | 5,389,402,984.11 | 5,364,370,475.41 | 5,331,865,791.35 |
| 少数股东权益 | 1,304,344,179.42 | 1,285,210,103.47 | 1,241,213,059.84 | 1,222,747,119.13 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 6,751,871,720.07 | 6,674,613,087.58 | 6,605,583,535.25 | 6,554,612,910.48 |
| 负债和股东权益合计 | 21,994,031,603.41 | 21,471,458,316.43 | 21,706,791,241.09 | 21,751,363,712.71 |
| 公告日期 | 2025-04-24 | 2025-03-28 | 2024-10-26 | 2024-08-14 |
| 审计意见(境内) | | 标准无保留意见 | | |